|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$83,493.13 |
2.38% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$81,451.12 |
2.32% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$79,087.70 |
2.26% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$78,837.03 |
2.25% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$78,533.35 |
2.24% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$78,459.15 |
2.24% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$78,301.21 |
2.23% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$78,054.46 |
2.23% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$77,750.35 |
2.22% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$76,506.51 |
2.18% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$76,583.57 |
2.18% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$75,784.67 |
2.16% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$75,886.08 |
2.16% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$75,757.92 |
2.16% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$74,626.87 |
2.13% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$74,644.70 |
2.13% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$74,157.42 |
2.12% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$74,339.26 |
2.12% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$73,875.20 |
2.11% |
| Steris Plc |
STE |
G8473T100 |
298 |
$73,877.18 |
2.11% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$72,798.12 |
2.08% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$72,797.10 |
2.08% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$72,649.49 |
2.07% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$71,930.13 |
2.05% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$71,483.59 |
2.04% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$71,536.50 |
2.04% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$70,881.03 |
2.02% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$70,652.84 |
2.02% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$69,615.50 |
1.99% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$69,720.56 |
1.99% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$68,592.54 |
1.96% |
| Waters Corporation |
WAT |
941848103 |
147 |
$68,737.20 |
1.96% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$68,364.63 |
1.95% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$68,497.52 |
1.95% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$67,741.63 |
1.93% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$67,634.25 |
1.93% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$67,244.80 |
1.92% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$66,861.78 |
1.91% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$67,065.00 |
1.91% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$66,438.75 |
1.90% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$66,498.25 |
1.90% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$66,431.79 |
1.89% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$66,163.45 |
1.89% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,490.00 |
1.84% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$63,285.24 |
1.81% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$61,570.34 |
1.76% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$61,264.09 |
1.75% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,646.77 |
1.59% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,544.01 |
1.27% |
| US Dollar |
$USD |
|
24,483 |
$24,482.69 |
0.70% |
| Japanese Yen |
$JPY |
|
42,336 |
$267.24 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|